CN Stock MarketDetailed Quotes

600055 Beijing Wandong Medical Technology

Watchlist
  • 14.57
  • +0.10+0.69%
Trading May 22 14:54 CST
10.24BMarket Cap53.57P/E (TTM)

Beijing Wandong Medical Technology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
20.94%308.5M
10.30%1.24B
26.36%925.79M
30.19%594.33M
21.12%255.08M
-3.02%1.12B
-8.50%732.66M
-7.74%456.52M
-12.25%210.6M
2.14%1.16B
Operating revenue
20.94%308.5M
10.30%1.24B
26.36%925.79M
30.19%594.33M
21.12%255.08M
-3.02%1.12B
-8.50%732.66M
-7.74%456.52M
-12.25%210.6M
2.14%1.16B
Other operating revenue
----
39.65%75.73M
----
2.34%24.44M
----
0.14%54.23M
----
11.95%23.88M
----
2.90%54.15M
Total operating cost
19.44%277.82M
16.23%1.11B
32.14%825.71M
32.67%528.91M
22.00%232.59M
-3.55%951.61M
-8.81%624.9M
-5.72%398.68M
0.43%190.66M
15.09%986.59M
Operating cost
26.08%192.94M
13.72%712.58M
32.60%540.76M
38.32%352.26M
38.87%153.03M
0.03%626.61M
-2.12%407.82M
-0.38%254.67M
-5.45%110.2M
11.51%626.4M
Operating tax surcharges
-50.66%761.83K
-21.07%11.86M
-7.77%7.35M
-0.67%5.87M
1.73%1.54M
0.46%15.02M
-6.81%7.97M
-6.37%5.91M
-16.31%1.52M
-12.95%14.95M
Operating expense
3.98%49.63M
27.98%223.26M
38.96%163.75M
34.52%106.16M
21.33%47.73M
-5.93%174.46M
-17.14%117.83M
-10.69%78.92M
8.78%39.34M
28.28%185.46M
Administration expense
-3.67%17.95M
19.32%80.77M
14.37%58.29M
17.01%40.55M
-1.51%18.63M
-4.05%67.69M
-0.10%50.96M
-7.76%34.65M
4.54%18.92M
11.26%70.55M
Financial expense
-8.52%-18.66M
-14.42%-80.01M
-24.32%-54.21M
-63.20%-40.5M
-311.88%-17.19M
-214.34%-69.92M
-653.32%-43.61M
-682.87%-24.82M
-108.04%-4.17M
-37.96%-22.24M
-Interest expense (Financial expense)
----
-14.40%1.25M
-1.15%568.85K
13.30%393.47K
--98.14K
-2.61%1.47M
--575.49K
--347.27K
----
-27.68%1.51M
-Interest Income (Financial expense)
-0.16%-18.72M
-31.42%-81.13M
-54.45%-50.91M
-87.87%-36.23M
-304.51%-18.69M
-136.48%-61.73M
-409.60%-32.96M
-384.52%-19.28M
-152.20%-4.62M
-13.46%-26.1M
Research and development
21.98%35.19M
14.38%157.56M
30.82%109.77M
30.86%64.57M
16.04%28.85M
23.57%137.76M
15.47%83.91M
29.26%49.34M
29.24%24.86M
29.01%111.48M
Credit Impairment Loss
----
67.58%-7.45M
143.95%2.91M
143.95%2.91M
5,571.88%85.24K
-33.42%-22.99M
-50.79%-6.62M
-51.18%-6.62M
---1.56K
45.41%-17.23M
Asset Impairment Loss
----
55.09%-2.11M
48.53%1.52K
48.53%1.52K
----
31.62%-4.7M
-99.86%1.02K
-99.60%1.02K
----
45.03%-6.87M
Other net revenue
-46.93%6.88M
260.20%82.68M
84.90%46.2M
117.59%28.58M
23.04%12.97M
-41.38%22.95M
-31.06%24.99M
-54.57%13.14M
21.07%10.54M
464.36%39.16M
Fair value change income
----
1,096.13%34.59M
100.88%53.57K
101.02%53.57K
101.17%53.57K
-61.98%-3.47M
-1,677.57%-6.11M
-1,421.32%-5.23M
---4.56M
91.93%-2.14M
Invest income
-77.01%131.43K
-61.25%8.29M
-63.30%5.24M
-82.14%1.69M
-92.13%571.64K
1.93%21.39M
12.92%14.29M
-18.15%9.48M
156.38%7.27M
10.94%20.99M
-Including: Investment income associates
111.03%28.28K
-951.31%-2.05M
-518.24%-925.01K
-400.49%-475.13K
-535.08%-256.5K
-149.64%-195.21K
-66.50%221.17K
-70.67%158.12K
-82.04%58.96K
45.44%393.23K
Asset deal income
----
83.13%-301.52K
100.47%1.12K
126.55%58.07K
113.74%38.52K
-648.78%-1.79M
-53.80%-241.15K
-50.67%-218.72K
-135.92%-280.35K
-168.91%-238.65K
Other revenue
-44.75%6.75M
43.92%49.66M
60.52%37.99M
51.84%23.87M
50.59%12.22M
-22.72%34.51M
-14.65%23.67M
-28.35%15.72M
35.48%8.11M
9.98%44.65M
Operating profit
5.93%37.56M
10.79%213.33M
10.20%146.28M
32.44%94M
16.32%35.46M
-7.76%192.55M
-12.47%132.74M
-29.63%70.98M
-48.21%30.48M
-20.92%208.74M
Add:Non operating Income
----
4,150.52%866.89K
18,925.67%11.42K
17,925.67%10.82K
--3.46K
883.19%20.39K
-97.11%60
-97.11%60
----
-64.24%2.07K
Less:Non operating expense
85.22%21.41K
564.09%860.99K
--523.48K
--29.74K
--11.56K
-91.47%129.65K
----
----
----
655.14%1.52M
Total profit
5.89%37.54M
10.86%213.33M
9.81%145.77M
32.41%93.99M
16.30%35.45M
-7.14%192.44M
-12.35%132.74M
-29.49%70.98M
-48.21%30.48M
-21.44%207.22M
Less:Income tax cost
-41.74%3.37M
10.41%22.52M
-18.70%23.94M
43.10%16.34M
13.28%5.78M
-24.33%20.4M
-7.64%29.45M
-36.84%11.42M
-49.53%5.1M
-40.73%26.96M
Net profit
15.16%34.17M
10.91%190.81M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.56%172.04M
-13.61%103.29M
-27.88%59.56M
-47.94%25.38M
-17.41%180.26M
Net profit from continuing operation
15.16%34.17M
10.91%190.81M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.56%172.04M
-13.61%103.29M
-27.88%59.56M
-47.94%25.38M
-17.41%180.26M
Less:Minority Profit
219.72%915.58K
168.18%2.27M
873.45%1.64M
545.42%1.6M
-201.96%-764.8K
-13.73%-3.33M
122.55%168.46K
139.42%248.14K
408.07%750.13K
-22.28%-2.93M
Net profit of parent company owners
9.26%33.26M
7.51%188.54M
16.54%120.18M
28.21%76.04M
23.57%30.44M
-4.27%175.37M
-14.29%103.13M
-28.72%59.31M
-49.73%24.63M
-16.98%183.19M
Earning per share
Basic earning per share
9.30%0.047
0.00%0.27
6.88%0.171
10.00%0.11
-6.52%0.043
-20.59%0.27
-28.25%0.16
-33.33%0.1
-49.45%0.046
-17.07%0.34
Diluted earning per share
9.30%0.047
0.00%0.27
6.88%0.171
10.00%0.11
-6.52%0.043
-20.59%0.27
-28.25%0.16
-33.33%0.1
-49.45%0.046
-17.07%0.34
Other composite income
-100.25%-1.35M
-48.41%-674.9K
-636.44%-454.75K
Other composite income of parent company owners
----
-100.25%-1.35M
----
----
----
-48.41%-674.9K
----
----
----
-636.44%-454.75K
Total composite income
15.16%34.17M
10.56%189.46M
17.94%121.82M
30.36%77.64M
16.90%29.67M
-4.70%171.36M
-13.61%103.29M
-27.88%59.56M
-47.94%25.38M
-17.60%179.81M
Total composite income of parent company owners
9.26%33.26M
7.15%187.19M
16.54%120.18M
28.21%76.04M
23.57%30.44M
-4.40%174.69M
-14.29%103.13M
-28.72%59.31M
-49.73%24.63M
-17.17%182.74M
Total composite income of minority owners
219.72%915.58K
168.18%2.27M
873.45%1.64M
545.42%1.6M
-201.96%-764.8K
-13.73%-3.33M
122.55%168.46K
139.42%248.14K
408.07%750.13K
-22.28%-2.93M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 20.94%308.5M10.30%1.24B26.36%925.79M30.19%594.33M21.12%255.08M-3.02%1.12B-8.50%732.66M-7.74%456.52M-12.25%210.6M2.14%1.16B
Operating revenue 20.94%308.5M10.30%1.24B26.36%925.79M30.19%594.33M21.12%255.08M-3.02%1.12B-8.50%732.66M-7.74%456.52M-12.25%210.6M2.14%1.16B
Other operating revenue ----39.65%75.73M----2.34%24.44M----0.14%54.23M----11.95%23.88M----2.90%54.15M
Total operating cost 19.44%277.82M16.23%1.11B32.14%825.71M32.67%528.91M22.00%232.59M-3.55%951.61M-8.81%624.9M-5.72%398.68M0.43%190.66M15.09%986.59M
Operating cost 26.08%192.94M13.72%712.58M32.60%540.76M38.32%352.26M38.87%153.03M0.03%626.61M-2.12%407.82M-0.38%254.67M-5.45%110.2M11.51%626.4M
Operating tax surcharges -50.66%761.83K-21.07%11.86M-7.77%7.35M-0.67%5.87M1.73%1.54M0.46%15.02M-6.81%7.97M-6.37%5.91M-16.31%1.52M-12.95%14.95M
Operating expense 3.98%49.63M27.98%223.26M38.96%163.75M34.52%106.16M21.33%47.73M-5.93%174.46M-17.14%117.83M-10.69%78.92M8.78%39.34M28.28%185.46M
Administration expense -3.67%17.95M19.32%80.77M14.37%58.29M17.01%40.55M-1.51%18.63M-4.05%67.69M-0.10%50.96M-7.76%34.65M4.54%18.92M11.26%70.55M
Financial expense -8.52%-18.66M-14.42%-80.01M-24.32%-54.21M-63.20%-40.5M-311.88%-17.19M-214.34%-69.92M-653.32%-43.61M-682.87%-24.82M-108.04%-4.17M-37.96%-22.24M
-Interest expense (Financial expense) -----14.40%1.25M-1.15%568.85K13.30%393.47K--98.14K-2.61%1.47M--575.49K--347.27K-----27.68%1.51M
-Interest Income (Financial expense) -0.16%-18.72M-31.42%-81.13M-54.45%-50.91M-87.87%-36.23M-304.51%-18.69M-136.48%-61.73M-409.60%-32.96M-384.52%-19.28M-152.20%-4.62M-13.46%-26.1M
Research and development 21.98%35.19M14.38%157.56M30.82%109.77M30.86%64.57M16.04%28.85M23.57%137.76M15.47%83.91M29.26%49.34M29.24%24.86M29.01%111.48M
Credit Impairment Loss ----67.58%-7.45M143.95%2.91M143.95%2.91M5,571.88%85.24K-33.42%-22.99M-50.79%-6.62M-51.18%-6.62M---1.56K45.41%-17.23M
Asset Impairment Loss ----55.09%-2.11M48.53%1.52K48.53%1.52K----31.62%-4.7M-99.86%1.02K-99.60%1.02K----45.03%-6.87M
Other net revenue -46.93%6.88M260.20%82.68M84.90%46.2M117.59%28.58M23.04%12.97M-41.38%22.95M-31.06%24.99M-54.57%13.14M21.07%10.54M464.36%39.16M
Fair value change income ----1,096.13%34.59M100.88%53.57K101.02%53.57K101.17%53.57K-61.98%-3.47M-1,677.57%-6.11M-1,421.32%-5.23M---4.56M91.93%-2.14M
Invest income -77.01%131.43K-61.25%8.29M-63.30%5.24M-82.14%1.69M-92.13%571.64K1.93%21.39M12.92%14.29M-18.15%9.48M156.38%7.27M10.94%20.99M
-Including: Investment income associates 111.03%28.28K-951.31%-2.05M-518.24%-925.01K-400.49%-475.13K-535.08%-256.5K-149.64%-195.21K-66.50%221.17K-70.67%158.12K-82.04%58.96K45.44%393.23K
Asset deal income ----83.13%-301.52K100.47%1.12K126.55%58.07K113.74%38.52K-648.78%-1.79M-53.80%-241.15K-50.67%-218.72K-135.92%-280.35K-168.91%-238.65K
Other revenue -44.75%6.75M43.92%49.66M60.52%37.99M51.84%23.87M50.59%12.22M-22.72%34.51M-14.65%23.67M-28.35%15.72M35.48%8.11M9.98%44.65M
Operating profit 5.93%37.56M10.79%213.33M10.20%146.28M32.44%94M16.32%35.46M-7.76%192.55M-12.47%132.74M-29.63%70.98M-48.21%30.48M-20.92%208.74M
Add:Non operating Income ----4,150.52%866.89K18,925.67%11.42K17,925.67%10.82K--3.46K883.19%20.39K-97.11%60-97.11%60-----64.24%2.07K
Less:Non operating expense 85.22%21.41K564.09%860.99K--523.48K--29.74K--11.56K-91.47%129.65K------------655.14%1.52M
Total profit 5.89%37.54M10.86%213.33M9.81%145.77M32.41%93.99M16.30%35.45M-7.14%192.44M-12.35%132.74M-29.49%70.98M-48.21%30.48M-21.44%207.22M
Less:Income tax cost -41.74%3.37M10.41%22.52M-18.70%23.94M43.10%16.34M13.28%5.78M-24.33%20.4M-7.64%29.45M-36.84%11.42M-49.53%5.1M-40.73%26.96M
Net profit 15.16%34.17M10.91%190.81M17.94%121.82M30.36%77.64M16.90%29.67M-4.56%172.04M-13.61%103.29M-27.88%59.56M-47.94%25.38M-17.41%180.26M
Net profit from continuing operation 15.16%34.17M10.91%190.81M17.94%121.82M30.36%77.64M16.90%29.67M-4.56%172.04M-13.61%103.29M-27.88%59.56M-47.94%25.38M-17.41%180.26M
Less:Minority Profit 219.72%915.58K168.18%2.27M873.45%1.64M545.42%1.6M-201.96%-764.8K-13.73%-3.33M122.55%168.46K139.42%248.14K408.07%750.13K-22.28%-2.93M
Net profit of parent company owners 9.26%33.26M7.51%188.54M16.54%120.18M28.21%76.04M23.57%30.44M-4.27%175.37M-14.29%103.13M-28.72%59.31M-49.73%24.63M-16.98%183.19M
Earning per share
Basic earning per share 9.30%0.0470.00%0.276.88%0.17110.00%0.11-6.52%0.043-20.59%0.27-28.25%0.16-33.33%0.1-49.45%0.046-17.07%0.34
Diluted earning per share 9.30%0.0470.00%0.276.88%0.17110.00%0.11-6.52%0.043-20.59%0.27-28.25%0.16-33.33%0.1-49.45%0.046-17.07%0.34
Other composite income -100.25%-1.35M-48.41%-674.9K-636.44%-454.75K
Other composite income of parent company owners -----100.25%-1.35M-------------48.41%-674.9K-------------636.44%-454.75K
Total composite income 15.16%34.17M10.56%189.46M17.94%121.82M30.36%77.64M16.90%29.67M-4.70%171.36M-13.61%103.29M-27.88%59.56M-47.94%25.38M-17.60%179.81M
Total composite income of parent company owners 9.26%33.26M7.15%187.19M16.54%120.18M28.21%76.04M23.57%30.44M-4.40%174.69M-14.29%103.13M-28.72%59.31M-49.73%24.63M-17.17%182.74M
Total composite income of minority owners 219.72%915.58K168.18%2.27M873.45%1.64M545.42%1.6M-201.96%-764.8K-13.73%-3.33M122.55%168.46K139.42%248.14K408.07%750.13K-22.28%-2.93M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg